tirzepatide cardiovascular outcomes trial results august 2025 Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of in HFpEF: The SUMMIT Effects of Tirzepatide in Type

Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of drugs

It works by targeting two hormone pathways involved in: Appetite regulation Insulin secretion Blood sugar control Energy balance By activating both GLP-1 and GIP receptors, tirzepatide may provide enhanced appetite suppression and metabolic support compared to single-pathway therapies

Problems with your pancreas and gallbladder are rare but serious side effects of tirzepatide, so its worth getting checked just in case

This does not guarantee safety, but it provides the theoretical foundation for why researchers suspected these medications might be compatible with breastfeeding long before human studies confirmed it